Juno Therapeutics CEO Bishop on Immunotherapy – Bloomberg
Bloomberg |
Juno Therapeutics CEO Bishop on Immunotherapy
Bloomberg Juno Therapeutics CEO Hans Bishop discusses the company's immunotherapy for cancer. He speaks with Erik Schatzker on "Bloomberg Technology" from the JPMorgan Healthcare Conference. (Source: Bloomberg) … |
